Press What’s news at AbelsonTaylor Group
Select category
An Indie POV on the Omnicom-Interpublic Merger
AT Group President Jeff Berg recently joined MM+M’s Jack O’Brien to discuss the future of the medical advertising industry in light of the Omnicom-Interpublic merger, highlighting how independent agencies “can bring to the table a more personalized approach.”
Listen to the podcast at the An indie POV on the big ad hold-co merger – MM+M Podcast Thank you!
Media Contact:
Recent Posts
Pharma brands are struggling to keep the attention of digitally savvy HCPs
Lynnette Hunter, EVP, Director of Client Services, talks to MM+M’s Jack O’Brien about what a digitally savvy HCP is in...
Read Press Read more Pharma brands are struggling to keep the attention of digitally savvy HCPsSix steps to navigating the future of pharmaceutical advertising
Terence Prudhomme, Senior Media Director for AT Activate, discusses six steps to optimizing the evolving media landscape for pharma advertisers to communicate...
Read Press Read more Six steps to navigating the future of pharmaceutical advertisingHow will medical marketing’s DE&I efforts fare in 2025?
Antonio Rivera, director of engagement at AbelsonTaylor Group, discusses how as AI becomes more embedded in healthcare and marketing, it...
In the News Read more How will medical marketing’s DE&I efforts fare in 2025?Connect with us
Find out what's top of mind for the people reimagining health and wellness advertising.